 Your new post is loading...
 Your new post is loading...
|
Scooped by
Ed Rybicki
May 18, 2016 1:42 PM
|
By John Summerly. Originally published on PreventDisease.com INTRODUCTION Forget the flu shot.
|
Scooped by
Ed Rybicki
May 18, 2016 1:38 PM
|
Why doctors are comparing parts of metro Atlanta to third world African counties and who’s most at risk, Friday at 5.
|
Scooped by
Ed Rybicki
May 18, 2016 4:32 AM
|
A report in the journal Science reveals how evolution harnessed viral DNA to rewire humans’ own genetic circuitry and strengthen the immune system.
|
Scooped by
Ed Rybicki
May 18, 2016 4:27 AM
|
Abundant bioinformatics resources are available for the study of complex microbial metagenomes, however their utility in viral metagenomics is limited. HoloVir is a robust and flexible data analysis pipeline that provides an optimised and validated workflow for taxonomic and functional characterisation of viral metagenomes derived from invertebrate holobionts. Simulated viral metagenomes comprising varying levels of viral diversity and abundance were used to determine the optimal assembly and gene prediction strategy, and multiple sequence assembly methods and gene prediction tools were tested in order to optimize our analysis workflow. HoloVir performs pairwise comparisons of single read and predicted gene datasets against the viral RefSeq database to assign taxonomy and additional comparison to phage-specific and cellular markers is undertaken to support the taxonomic assignments and identify potential cellular contamination. Broad functional classification of the predicted genes is provided by assignment of COG microbial functional category classifications using EggNOG and higher resolution functional analysis is achieved by searching for enrichment of specific Swiss-Prot keywords within the viral metagenome. Application of HoloVir to viral metagenomes from the coral Pocillopora damicornis and the sponge Rhopaloeides odorabile demonstrated that HoloVir provides a valuable tool to characterise holobiont viral communities across species, environments, or experiments.
|
Scooped by
Ed Rybicki
May 12, 2016 12:21 PM
|
Complaints about unreliable data, staffing problems and stockouts, but Health Department denies there’s a problem. By Stephanie Kelly for GROUNDUP.
|
Scooped by
Ed Rybicki
May 12, 2016 12:20 PM
|
An unprecedented molecular view of the critical early events in gene expression, a process essential for all life, has been provided by researchers at Georgia State University, the University of California at Berkeley an...
|
Scooped by
Ed Rybicki
May 12, 2016 12:17 PM
|
In the past few years, influenza D virus has been identified in cattle in the United States, France, and China.
|
Scooped by
Ed Rybicki
May 12, 2016 9:12 AM
|
Virology Journal is now accepting manuscript submissions to be considered for publication in a thematic series on Coronaviruses: emerging and re-emerging pathogens in humans and animals. Edited by Susanna Kar-Pui Lau (The University of Hong Kong, Hong Kong), the collection will accept Research and Review manuscript submissions, and will also include commissioned topical reviews, written by leaders in the field. Some of the coronavirus infections raise very serious problems in the past 2 decades, such as the severe acute respiratory syndrome (SARS) outbreak in 2003, and porcine epidemic diarrhea virus (PEDV) which has caused millions of deaths in piglets worldwide. More recently, we are threatened by the outbreak of Middle East respiratory syndrome (MERS) which has spread to various countries including South Korea. A thematic series to explore these emerging and re-emerging diseases will be a timely addition to the academic literature. The series will cover many aspects of the coronaviruses, including (but not limited to) the origin, molecular epidemiology, transmission, diagnostics of coronaviruses, and will provide updates on the situation of MERS infection in South Korea. The deadline for submissions is June 30th 2016. To submit your manuscript, please use our online submission system, and indicate in your covering letter that you would like the manuscript to be considered for the ‘Coronaviruses: emerging and re-emerging pathogens in humans and animals’ thematic series. If you would like to enquire about the suitability of a manuscript for consideration, please email a pre-submission enquiry to virologyjournal@biomedcentral.com.
|
Scooped by
Ed Rybicki
May 12, 2016 8:49 AM
|
Hospitals and care homes are commonly under the threat of “superbugs” which develop to become drug-resistant, including bacterial biofilms and respiratory viruses--both notoriously difficult to treat. Now researchers at the University of Pittsburgh Center for Vaccine Research say they may have an answer that could trump therapies that are currently used in the clinic.
|
Scooped by
Ed Rybicki
May 12, 2016 8:46 AM
|
Scientists have designed a macromolecule that can fight both infection and prevent drug resistance. It has been tested on viruses from various categories - including Zika, Ebola, dengue, influenza, and herpes simplex - and scientists have not found any resistance after early testing.
|
Scooped by
Ed Rybicki
May 10, 2016 9:34 AM
|
If you tried to to watch Mercury crossing in front of the Sun yesterday, chances are you didn’t get as good a view as NASA’s Solar Dynamics Observatory. Mercifully, the space agency has put together a stunning time lapse so you can watch the spectacle again.
|
Scooped by
Ed Rybicki
May 10, 2016 5:59 AM
|
A potential drug therapy developed at the University of Pittsburgh Center for Vaccine Research (CVR) has proven effective against tough bacterial biofilms and a deadly respiratory virus simultaneously. The drug outperforms traditional therapies in the laboratory setting. The results, reported in the journal mSphere, build on a recent discovery from Pitt's School of Medicine showing that the virus encourages biofilm growth and point to a new way to treat drug-resistant bacteria, including so-called "superbugs" that are resistant to almost all existing antibiotics and have become the focus of worldwide efforts to limit their spread.
|
Scooped by
Ed Rybicki
May 9, 2016 10:34 AM
|
Researchers in Malaysia and Japan have found that birdcages kept at home may be a breeding site for mosquitoes that transmit dengue virus to humans. Bird keeping for personal or commercial purposes is as common in Malaysia as in the rest of South-East Asia. However, birdcages could provide an ideal environment for the development of mosquitoes that transmit dengue virus to humans. Dengue fever is a debilitating and sometimes deadly disease caused by a virus transmitted by mosquitoes. Its symptoms include fever, headache, rash, muscle and joint pain, and sometimes severe bleeding. Researchers have found that mosquito larvae can grow in bird faeces dropped into birdcage water bowls. Previous research found various developmental stages of the mosquito Aedes albopictus in the water containers of birdcages in rural homes of peninsular Malaysia. Aedes albopictus can transmit more than 20 diseases to humans, including dengue. Researchers were unsure, however, whether bird droppings contributed to the development and population maintenance of these mosquitoes. Hamady Dieng of Universiti Malaysia Sarawak with colleagues from Malaysia and Japan found that A. albopictus can breed on bird faeces as effectively as when they are cultured under laboratory conditions with standard mosquito feed.
|
|
Scooped by
Ed Rybicki
May 18, 2016 1:40 PM
|
The WHO declared the Zika virus a global health emergency on February 1 without providing much detail on the disease. Zika is both a virus as well as a de facto commodity. Guess who owns th
|
Scooped by
Ed Rybicki
May 18, 2016 1:37 PM
|
The HVTN 702 vaccine regimen consists of two experimental vaccines: a canarypox-based vaccine called ALVAC-HIV and a bivalent gp120 protein subunit vaccine with an adjuvant that enhances the body’s immune response to the vaccine. Both ALVAC-HIV (supplied by Sanofi Pasteur) and the protein vaccine (supplied by GSK) have been modified from RV144 to be specific to HIV subtype C, the predominant HIV subtype in southern Africa. In addition, the protein subunit vaccine in HVTN 702 is combined with MF59 (also supplied by GSK), a different adjuvant than the one used in RV144, in the hope of generating a more robust immune response. Finally, the HVTN 702 vaccine regimen will include booster shots at the one-year mark in an effort to prolong the early protective effect observed in RV144.
|
Scooped by
Ed Rybicki
May 18, 2016 4:30 AM
|
Viruses interact with hundreds to thousands of proteins in mammals, yet adaptation against viruses has only been studied in a few proteins specialized in antiviral defense. Whether adaptation to viruses typically involves only specialized antiviral proteins or affects a broad array of virus-interacting proteins is unknown. Here, we analyze adaptation in ~1300 virus-interacting proteins manually curated from a set of 9900 proteins conserved in all sequenced mammalian genomes. We show that viruses (i) use the more evolutionarily constrained proteins within the cellular functions they interact with and that (ii) despite this high constraint, virus-interacting proteins account for a high proportion of all protein adaptation in humans and other mammals. Adaptation is elevated in virus-interacting proteins across all functional categories, including both immune and non-immune functions. We conservatively estimate that viruses have driven close to 30% of all adaptive amino acid changes in the part of the human proteome conserved within mammals. Our results suggest that viruses are one of the most dominant drivers of evolutionary change across mammalian and human proteomes.
|
Scooped by
Ed Rybicki
May 16, 2016 3:12 AM
|
Although ZIKV was estimated to have emerged between 1892 and 1943 by Bayesian evolutionary analysis and has been isolated for nearly 70 years, very little is known about the virology of this emerging virus.60 In this study, we summarized its genomic changes with a limited number of virus strains. These virus strains included both the pre-epidemic African and Asian lineage strains that were mostly mosquito isolates, and the epidemic strains found in human. Among these virus strains, we have detected a number of amino acid substitutions throughout the genome and a conformational change in the SLI structure at the 3′-UTR of the epidemic ZIKV strain. We have also detected a possible recombination of a NS2B fragment between the Asian lineage of ZIKV and SPOV. The impact of these changes of the virus genome on the virulence, viability and transmissibility of ZIKV should be further investigated in biological assays.
|
Scooped by
Ed Rybicki
May 12, 2016 12:20 PM
|
Early detection and prediction of influenza outbreaks is critical to minimizing their impact. Currently, flu-like illnesses are tracked by the Centers for Disease Control and Prevention, but with a ti..
|
Scooped by
Ed Rybicki
May 12, 2016 12:19 PM
|
Washington State University Spokane scientists have found a brain protein that boosts the healing power of sleep and speeds an animal's recovery from the flu. Research by WSU Regents Professor James M.
|
Scooped by
Ed Rybicki
May 12, 2016 12:14 PM
|
IMPORTANCE Primates are an important source of viruses that infect humans and serve as an important laboratory model of human virus infection. Here, we discover two new viruses in African green monkeys from Zambia and South Africa. In combination with previous virus discovery efforts, this finding suggests that these virus types are widespread among African monkeys. Our analysis suggests that one of these virus types, the simian arteriviruses, may have the potential to jump between different primate species and cause disease. In contrast, the other virus type, the pegiviruses, are thought to reduce the disease caused by HIV in humans. However, we did not observe a similar protective effect in SIV-infected African monkeys co-infected with pegiviruses, possibly because SIV causes little-to-no disease in these hosts.
|
Scooped by
Ed Rybicki
May 12, 2016 8:52 AM
|
Eradicating HIV is within our grasp, using the 'treatment as prevention' approach, experts have suggested. Across the world, around 35 million people are afflicted and living with the virus. The World Health Organization and the Joint United Nations Programme on HIV/AIDS said they plan to use the 'treatment as prevention' technique to eliminate the global pandemic. The point will have been achieved, WHO experts say, when only one person in every 1,000 becomes infected each year. Now, a nearly two-decade analysis by researchers from UCLA and Denmark, yields the first proof that the approach could be effective. Reviewing Danish medical records, they found that the treatment-as-prevention strategy has brought Denmark's HIV epidemic to the brink of elimination.
|
Scooped by
Ed Rybicki
May 12, 2016 8:47 AM
|
Setting Australia’s gay agenda since 1979
|
Scooped by
Ed Rybicki
May 11, 2016 8:33 AM
|
Virology Highlights features highlighted articles published in Virology, with posts summarizing the research in the authors’ words.
|
Scooped by
Ed Rybicki
May 10, 2016 6:02 AM
|
Jet-drying technology spreads infectious agents much further than paper towels.
|
Scooped by
Ed Rybicki
May 10, 2016 5:58 AM
|
A community-based hepatitis B virus screening effort led by UC Davis researchers found that targeted outreach to Asian American populations can identify groups at high risk for infection and direct them to appropriate follow-up care to help prevent the onset of liver diseases, including cancer. Published online in Public Health Reports, the research involved screening 1,004 Asian American adults in Sacramento County at 28 different events over a one-year period. An outreach team from the UC Davis Comprehensive Cancer Center worked with Asian American community organizations and the UC Davis student-run clinics to promote and co-sponsor hepatitis B screening events. The effort was part of the national Hepatitis Testing and Linkage to Care Initiative, which aims to test those at highest risk for infection and to get those who test positive additional tests and counseling about next steps.
|